Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,354 | 783 | 87.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,700 | 2 | 8.5% |
| Travel and Lodging | $638.85 | 3 | 3.2% |
| Education | $117.89 | 9 | 0.6% |
| Entertainment | $76.87 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,436 | 258 | $0 (2024) |
| Allergan, Inc. | $2,840 | 21 | $0 (2020) |
| Janssen Biotech, Inc. | $1,277 | 59 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,207 | 82 | $0 (2024) |
| GENZYME CORPORATION | $947.77 | 34 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $702.08 | 25 | $0 (2024) |
| PFIZER INC. | $581.16 | 30 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $542.19 | 6 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $532.73 | 46 | $0 (2024) |
| Gilead Sciences, Inc. | $515.81 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,752 | 155 | ABBVIE INC. ($635.59) |
| 2023 | $3,161 | 127 | ABBVIE INC. ($810.92) |
| 2022 | $2,786 | 132 | ABBVIE INC. ($1,046) |
| 2021 | $1,828 | 104 | AbbVie Inc. ($1,168) |
| 2020 | $1,220 | 68 | AbbVie Inc. ($472.72) |
| 2019 | $1,607 | 56 | AbbVie, Inc. ($352.36) |
| 2018 | $1,027 | 62 | AbbVie, Inc. ($403.37) |
| 2017 | $4,506 | 94 | Allergan Inc. ($2,752) |
All Payment Transactions
798 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: GI | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Immunology | ||||||
| 11/27/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/18/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $112.57 | General |
| Category: HCV | ||||||
| 11/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| Category: GI | ||||||
| 11/14/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $85.21 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/28/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Immunology | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 676 | 731 | $374,259 | $71,157 |
| 2022 | 15 | 647 | 725 | $370,069 | $73,363 |
| 2021 | 17 | 696 | 744 | $347,208 | $72,301 |
| 2020 | 18 | 627 | 724 | $291,541 | $63,674 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 158 | $61,858 | $13,602 | 22.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 72 | 72 | $57,096 | $9,137 | 16.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 43 | 43 | $40,549 | $8,974 | 22.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 96 | 100 | $60,000 | $8,599 | 14.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 44 | 44 | $32,868 | $7,789 | 23.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 33 | 33 | $24,651 | $5,729 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $19,662 | $3,946 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 54 | $14,841 | $3,043 | 20.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $14,940 | $2,665 | 17.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,400 | $1,126 | 25.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $4,896 | $1,100 | 22.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 13 | 21 | $4,830 | $962.73 | 19.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 24 | 24 | $5,304 | $791.53 | 14.9% |
| 43450 | Dilation of esophagus | Facility | 2023 | 24 | 25 | $16,650 | $785.96 | 4.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 12 | $2,520 | $746.28 | 29.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 19 | $2,185 | $742.33 | 34.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 14 | $3,192 | $725.48 | 22.7% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 11 | 11 | $3,817 | $691.35 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 143 | $55,978 | $12,785 | 22.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 76 | 76 | $60,268 | $10,386 | 17.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 44 | 44 | $41,492 | $8,708 | 21.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 95 | 99 | $59,400 | $8,682 | 14.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 41 | 41 | $30,627 | $7,094 | 23.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 32 | 32 | $23,904 | $5,801 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 73 | 73 | $24,747 | $5,688 | 23.0% |
About Dr. Anna Longacre, MD
Dr. Anna Longacre, MD is a Gastroenterology healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831118405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Longacre, MD has received a total of $19,887 in payments from pharmaceutical and medical device companies, with $3,752 received in 2024. These payments were reported across 798 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($17,354).
As a Medicare-enrolled provider, Longacre has provided services to 2,646 Medicare beneficiaries, totaling 2,924 services with total Medicare billing of $280,495. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Marietta, GA
- Active Since 07/18/2006
- Last Updated 12/29/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1831118405
Products in Payments
- LINZESS (Drug) $3,340
- DUPIXENT (Biological) $1,326
- STELARA (Biological) $1,156
- HUMIRA (Biological) $1,006
- XIFAXAN (Drug) $996.69
- Humira (Biological) $764.96
- SKYRIZI (Biological) $670.47
- RINVOQ (Biological) $643.80
- MAVYRET (Drug) $609.37
- OCALIVA (Drug) $586.53
- ZEPOSIA (Drug) $546.00
- Epclusa (Drug) $428.16
- XELJANZ (Drug) $395.17
- IBSRELA (Drug) $378.18
- DIFICID (Drug) $358.30
- REMICADE (Biological) $354.67
- VIBERZI (Drug) $346.65
- Linzess (Drug) $341.16
- Mavyret (Drug) $325.72
- TREMFYA (Drug) $308.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Marietta
Aasim Sheikh, Md, MD
Gastroenterology — Payments: $114,997
Michael Levine, Md, MD
Gastroenterology — Payments: $44,576
Ben Scheinfeld, M.d, M.D
Gastroenterology — Payments: $21,292
Basil Al-Awabdy, Md, MD
Gastroenterology — Payments: $20,738
Dr. Charles Nesmith, M.d, M.D
Gastroenterology — Payments: $12,704
Alberto Fernandez Bravo, Md, MD
Gastroenterology — Payments: $6,386